Kyle Bryant Translational Research Award

FARA accepts LOIs focusing on pre-clinical and clinical investigations that will advance treatments for FA.

The specific aims must target one or more of the following:

• Identification of biomarkers for FA that will elucidate disease variability, severity, and prognosis; facilitate drug screening, and/or optimize selection of patients and clinical endpoints for clinical trials;
• Development of tools and technologies that can
  (a) be directly used for therapy development;
  (b) overcome existing obstacles to treatment and
  (c) be directly applied to, or adapted for, delivery of potential therapeutics;
• Pre-clinical development and testing of potential therapeutics, biologics, and devices in cells and animals;
• Clinical studies of patient outcome measures.

Funding: $250,000
Duration: 1-2 years

Research Authority due date: 25.10.23

LOI (required) due date: 1.11.23

Full proposal due date: 1.2.24